Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18793871rdf:typepubmed:Citationlld:pubmed
pubmed-article:18793871lifeskim:mentionsumls-concept:C0021289lld:lifeskim
pubmed-article:18793871lifeskim:mentionsumls-concept:C0680063lld:lifeskim
pubmed-article:18793871lifeskim:mentionsumls-concept:C0012634lld:lifeskim
pubmed-article:18793871lifeskim:mentionsumls-concept:C0015965lld:lifeskim
pubmed-article:18793871lifeskim:mentionsumls-concept:C1412099lld:lifeskim
pubmed-article:18793871lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:18793871lifeskim:mentionsumls-concept:C1314792lld:lifeskim
pubmed-article:18793871lifeskim:mentionsumls-concept:C0312853lld:lifeskim
pubmed-article:18793871lifeskim:mentionsumls-concept:C0078140lld:lifeskim
pubmed-article:18793871pubmed:issue2lld:pubmed
pubmed-article:18793871pubmed:dateCreated2009-2-16lld:pubmed
pubmed-article:18793871pubmed:abstractTextABO hemolytic disease of fetus and newborn (ABO-HDFN) occurs almost exclusively in infants of blood group A or B who are born to group O mothers because IgG anti-A or -B occurs more commonly in group O than in group A or B individuals. We report a case of clinically significant ABO-HDFN where the mother was blood group O with elevated IgG anti-A and anti-B titers and delivered a child with an A2B phenotype. This unusual ABO constellation between mother and infant was based on the inheritance of a rare ABO allele encoding for a glycosyltransferase capable of synthesizing both A and B antigens. Because both anti-A and anti-B antibodies may have been involved in hemolysis in this case, it may be relevant to consider the cisAB phenomenon when monitoring ABO-incompatible pregnancies and births.lld:pubmed
pubmed-article:18793871pubmed:languageenglld:pubmed
pubmed-article:18793871pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18793871pubmed:citationSubsetTlld:pubmed
pubmed-article:18793871pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18793871pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18793871pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18793871pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18793871pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18793871pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18793871pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18793871pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18793871pubmed:statusMEDLINElld:pubmed
pubmed-article:18793871pubmed:monthOctlld:pubmed
pubmed-article:18793871pubmed:issn1473-0502lld:pubmed
pubmed-article:18793871pubmed:authorpubmed-author:SeltsamAxelAlld:pubmed
pubmed-article:18793871pubmed:authorpubmed-author:LiQianQlld:pubmed
pubmed-article:18793871pubmed:authorpubmed-author:SuYu-QingYQlld:pubmed
pubmed-article:18793871pubmed:authorpubmed-author:YuQiongQlld:pubmed
pubmed-article:18793871pubmed:authorpubmed-author:DengZhi-HuiZHlld:pubmed
pubmed-article:18793871pubmed:authorpubmed-author:LiangYan-Lian...lld:pubmed
pubmed-article:18793871pubmed:authorpubmed-author:YeYou-WanYWlld:pubmed
pubmed-article:18793871pubmed:authorpubmed-author:ZangHaoHlld:pubmed
pubmed-article:18793871pubmed:issnTypePrintlld:pubmed
pubmed-article:18793871pubmed:volume39lld:pubmed
pubmed-article:18793871pubmed:ownerNLMlld:pubmed
pubmed-article:18793871pubmed:authorsCompleteYlld:pubmed
pubmed-article:18793871pubmed:pagination123-8lld:pubmed
pubmed-article:18793871pubmed:meshHeadingpubmed-meshheading:18793871...lld:pubmed
pubmed-article:18793871pubmed:meshHeadingpubmed-meshheading:18793871...lld:pubmed
pubmed-article:18793871pubmed:meshHeadingpubmed-meshheading:18793871...lld:pubmed
pubmed-article:18793871pubmed:meshHeadingpubmed-meshheading:18793871...lld:pubmed
pubmed-article:18793871pubmed:meshHeadingpubmed-meshheading:18793871...lld:pubmed
pubmed-article:18793871pubmed:meshHeadingpubmed-meshheading:18793871...lld:pubmed
pubmed-article:18793871pubmed:meshHeadingpubmed-meshheading:18793871...lld:pubmed
pubmed-article:18793871pubmed:meshHeadingpubmed-meshheading:18793871...lld:pubmed
pubmed-article:18793871pubmed:meshHeadingpubmed-meshheading:18793871...lld:pubmed
pubmed-article:18793871pubmed:meshHeadingpubmed-meshheading:18793871...lld:pubmed
pubmed-article:18793871pubmed:meshHeadingpubmed-meshheading:18793871...lld:pubmed
pubmed-article:18793871pubmed:meshHeadingpubmed-meshheading:18793871...lld:pubmed
pubmed-article:18793871pubmed:meshHeadingpubmed-meshheading:18793871...lld:pubmed
pubmed-article:18793871pubmed:meshHeadingpubmed-meshheading:18793871...lld:pubmed
pubmed-article:18793871pubmed:meshHeadingpubmed-meshheading:18793871...lld:pubmed
pubmed-article:18793871pubmed:meshHeadingpubmed-meshheading:18793871...lld:pubmed
pubmed-article:18793871pubmed:meshHeadingpubmed-meshheading:18793871...lld:pubmed
pubmed-article:18793871pubmed:meshHeadingpubmed-meshheading:18793871...lld:pubmed
pubmed-article:18793871pubmed:meshHeadingpubmed-meshheading:18793871...lld:pubmed
pubmed-article:18793871pubmed:meshHeadingpubmed-meshheading:18793871...lld:pubmed
pubmed-article:18793871pubmed:meshHeadingpubmed-meshheading:18793871...lld:pubmed
pubmed-article:18793871pubmed:year2008lld:pubmed
pubmed-article:18793871pubmed:articleTitleHaemolytic disease of fetus and newborn caused by ABO antibodies in a cisAB offspring.lld:pubmed
pubmed-article:18793871pubmed:affiliationShenZhen Institute of Transfusion Medicine, ShenZhen Blood Center, ShenZhen, GuangDong, PR China. zhihui_deng@yahoo.com.com.cnlld:pubmed
pubmed-article:18793871pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18793871pubmed:publicationTypeCase Reportslld:pubmed
pubmed-article:18793871pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed